← Open Payments lookup

MATTHEW SPARKS: Open Payments

NPI 1063273019 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$419 in 15 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $123 · 2025 $419

Food & beverage: $419
CompanyPaymentsAmount
Lilly USA, LLC2$96
Novo Nordisk Inc2$96
ABBVIE INC.3$56
Exact Sciences Corporation2$44
Biogen, Inc.2$38
Vanda Pharmaceuticals Inc.1$27
Otsuka America Pharmaceutical, Inc.1$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Merck Sharp & Dohme LLC1$14

Products named: MOUNJARO, Ozempic, Cologuard Collection Kit, ZURZUVAE, VRAYLAR, FANAPT, REXULTI, UBRELVY.

Industry payments across TX — which companies pay providers there.